Friday, January 30, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Daqo New Energy Shares Plunge Following Disappointing Quarterly Results

Andreas Sommer by Andreas Sommer
August 27, 2025
in Stocks
0
Daqo New Energy Stock
0
SHARES
387
VIEWS
Share on FacebookShare on Twitter

Chinese polysilicon producer Daqo New Energy Corp. delivered a severe disappointment to investors with its second-quarter financial performance. The company reported a significant revenue shortfall and a substantial net loss, triggering a pre-market stock decline exceeding 15%. This dramatic sell-off reflects deeper challenges within the solar energy supply chain.

Severe Market Headwinds and Operational Challenges

Daqo’s operational metrics reveal the intensity of the pressure it faces. The global solar industry continues to grapple with substantial oversupply and bloated inventory levels. Polysilicon prices have been driven down so aggressively that they now trade below cash production costs. In response, Daqo was forced to implement drastic measures, slashing its production utilization rate to a mere 34%.

The financial impact was immediate and severe:
– Sales volume collapsed, falling from 28,008 metric tons (MT) in Q1 to just 18,126 MT.
– The average selling price (ASP) continued its descent, dropping from $4.37 to $4.19 per kilogram.
– A gross margin of -108.3% starkly illustrates the unsustainable pricing environment.

Despite achieving a slight improvement in production costs, which fell to $7.26 per kilogram, the company is operating deeply in the red.

Should investors sell immediately? Or is it worth buying Daqo New Energy?

Management Response: Buyback and Revised Guidance

In a move to counter the plunging share price, the company’s board of directors authorized a new $100 million stock repurchase program on Tuesday. This is a typical maneuver signaling management’s belief that the equity is undervalued.

Concurrently, Daqo revised its full-year outlook downward. The company now anticipates total production for the year will land between 110,000 and 130,000 MT. For the current quarter, management provided guidance of 27,000-30,000 MT, indicating operations will remain at a significantly reduced capacity.

Divergent Views from Wall Street

The investment community is sharply divided on Daqo’s future trajectory. In the wake of the earnings report, HSBC downgraded the stock to a “Hold” rating, assigning a price target of $14.00. In contrast, analysts at GLJ Research and Citigroup maintained their “Buy” stances, with bullish price targets of $30.51 and $27.00, respectively. This extreme disparity in price targets underscores the high degree of uncertainty among market participants regarding whether Daqo is poised for a recovery or faces further deterioration.

The central question remains whether a polysilicon market recovery can materialize before sustained losses critically weaken the company’s financial position. The coming quarters will be decisive for Daqo New Energy.

Ad

Daqo New Energy Stock: Buy or Sell?! New Daqo New Energy Analysis from January 30 delivers the answer:

The latest Daqo New Energy figures speak for themselves: Urgent action needed for Daqo New Energy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 30.

Daqo New Energy: Buy or sell? Read more here...

Tags: Daqo New Energy
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Nike Stock

Nike's Path to Recovery: Early Signs of Progress Amid Challenges

Viking Therapeutics Stock

Viking Therapeutics Shares Stabilize Following Steep Decline

Mesoblast Stock

Mesoblast Shares Face Critical Test with Back-to-Back Financial Updates

Recommended

Zscaler Stock

Zscaler Strengthens Cybersecurity Alliance with AI Integration

5 months ago
Healwell AI Stock

Healwell AI Shares Struggle to Gain Traction Despite Strong Revenue Growth

2 months ago
KO stock news

SunPower Co. Faces Uncertainty as Analysts Give Mixed Recommendations Amidst Volatile Market Conditions

3 years ago
Unitedhealth Stock

Political Scrutiny Mounts for UnitedHealth Over Rural Coverage Changes

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Viking Therapeutics Advances Weight-Loss Drug into Final Clinical Trials

Iqvia Strengthens Global Position Ahead of Earnings Report

iRobot’s Public Market Journey Concludes Following Acquisition

Tilray’s Mixed Quarter: Record Revenue Tempered by Beverage Weakness

SunHydrogen Secures Multi-Million Euro Deal to Scale Hydrogen Panel Production

Host Hotels & Resorts Eyes Major Portfolio Shift with Billion-Dollar Asset Sale

Trending

Ocugen Stock
Analysis

Ocugen Secures Funding to Advance Key Gene Therapy Trials

by Felix Baarz
January 30, 2026
0

Biotechnology firm Ocugen has bolstered its financial position through a recent capital raise, providing crucial resources as...

Coinbase Stock

Coinbase Navigates Market Turbulence with Strategic Diversification

January 30, 2026
Realty Income Stock

Realty Income Forges a $1.5 Billion Strategic Partnership for Growth

January 30, 2026
Viking Therapeutics Stock

Viking Therapeutics Advances Weight-Loss Drug into Final Clinical Trials

January 30, 2026
Iqvia Stock

Iqvia Strengthens Global Position Ahead of Earnings Report

January 30, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Ocugen Secures Funding to Advance Key Gene Therapy Trials
  • Coinbase Navigates Market Turbulence with Strategic Diversification
  • Realty Income Forges a $1.5 Billion Strategic Partnership for Growth

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com